I’ve often wondered what would happen if antibiotics stopped working. Many times I have been spared agonising pain or an uncomfortable fever through a course of antibiotics. I have seen an abscess cleared, and the threat of infection subsides as a result of their impact.
This is why reading about antibiotic-resistant infections in the news immediately caught my attention. I found myself asking: What are the implications if an infection doesn’t respond to antibiotics? Are there alternative treatments which are as effective as antibiotics if this is the case?
Recent news headlines highlighted a growing problem of antibiotic-resistant urinary tract infections (UTIs). More specifically, the Centres for Disease Control and Prevention in the US reported a 12 percent rise in multi-drug resistant UTIs. This statistic has been gathered from figures accumulated over the past year.
The result of these UTIs not responding to antibiotics can become serious. Experts warn that kidney infections and even sepsis could result.
This sharp increase in antibiotic-resistant UTIs coincides with other similar trends. Public Health England noted that resistant E. coli strains now account for nearly 30 percent of community-acquired UTIs.
Experts warn that these trends are indicative of a broader public health challenge. This is the improper use of antibiotics. This is accelerating resistance in UTIs, as well as in bloodstream infections, pneumonia, and other common bacterial infections.
As a Medscape article explains: “Rational antibiotic prescription involves more than choosing the correct drug. Appropriate indication, treatment duration, antibiotic selection, and ongoing monitoring are crucial. Consistently applying these principles supports evidence-based, patient-centered treatment and makes an effective contribution to the fight against antibiotic resistance.”
In the United States, UTIs remain one of the most frequently treated bacterial infections, particularly affecting women, older adults, and individuals with underlying conditions. The emergence of strains resistant to multiple classes of antibiotics, including fluoroquinolones, trimethoprim-sulfamethoxazole, and beta-lactams, has made standard treatments less reliable.
Dr. Sarah Patel, an infectious disease specialist at Johns Hopkins Hospital, has said, “We are seeing patients with UTIs who do not respond to standard antibiotics… This is a direct consequence of antibiotic overuse and improper stewardship.”
Similarly, the UK is grappling with rising resistance. Public Health England’s 2025 report highlighted that multi-drug resistant E. coli accounted for almost a third of community-acquired UTIs, a significant increase from previous years.
Dr. Emily Roberts, a consultant child and adolescent psychiatrist in London who advises on antimicrobial policy, noted, “We are facing a steady climb in resistant infections. Overprescription and inappropriate antibiotic use in primary care have allowed these strains to gain a foothold in the community.”
A Connection Between Stewardship Lapses And Resistance
The connection between stewardship lapses and resistance is evident in societies across the world. In the US, Dr. Robert Hastings, president of the Infectious Diseases Society of America, explained, “Antibiotics are often prescribed when they aren’t strictly necessary, or courses are not completed. Each misstep provides bacteria with an opportunity to adapt and survive.”
In the UK, general practitioners face numerous challenges. Although the NHS has implemented national guidelines to curb unnecessary prescriptions, studies show that up to 20 percent of antibiotic prescriptions in primary care could be avoided, particularly for viral infections and mild cases that might resolve without pharmacological intervention.
Globally, experts warn that the problem is not confined to a single infection or country. According to Dr. Hastings: “Antibiotic resistance is a universal problem. Lapses in stewardship anywhere, whether in the US or UK, have implications everywhere.
Resistant pathogens move across borders through travel, trade, and community spread.” The World Health Organisation has similarly highlighted the emergence of resistant strains of E. coli, MRSA, and Klebsiella as major global threats, emphasising the need for coordinated international action.
Interventions To Improve Antibiotic Stewardship
Numerous interventions to improve antibiotic stewardship are underway. Hospitals and clinics are implementing protocols to ensure antibiotics are prescribed only when indicated, and that full courses are completed.
Telemedicine platforms in the US are increasingly being used to support remote diagnosis and stewardship, while the NHS has invested in antimicrobial stewardship programmes, combining clinician education, audit systems, and public awareness campaigns.
Dr. Patel commented, “We are starting to see positive results where stewardship is taken seriously. However, adoption is uneven, and resistance continues to rise in regions where oversight is lacking.”
Patient education is another critical component. Authorities emphasise that antibiotics are not a cure-all and misuse can have lasting consequences. The CDC advises patients to avoid requesting antibiotics for viral infections and to complete prescribed courses when indicated.
In addition to educational campaigns, new innovations are underway. Research into novel antibiotics, bacteriophage therapy, and immunomodulatory treatments is ongoing. Still, as Dr. Hastings has emphasised, “Even with new drugs, if we do not use antibiotics responsibly, resistance will continue to rise. Stewardship is our best tool for preserving treatment options.”
Meanwhile, the rise of antibiotic-resistant UTIs continues to be a pressing concern for healthcare systems and patients alike. This is because patients with resistant UTIs often present with more severe and persistent symptoms, including intense pain, frequent urination, and, in some cases, kidney involvement or systemic infection.
Dr. Patricia Quinlan of the CDC has summed up the problem: “Resistant UTIs are a warning signal. They show us that inappropriate prescribing and incomplete courses of antibiotics have consequences that extend far beyond individual patients.”